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Abstract  
A comparative study of BCA patients on chemotherapy/radiotherapy and immune booster supplements (combination 
of essential vitamins and minerals) with apparently healthy controls was investigated by assessing the lipid profile, 
hepatic transaminases (plasma AST, ALT) total bilurubin, lipid peroxidation and enzymatic and non-enzymatic 
antioxidant-superoxide dismutase (SOD) activity and plasma vitamins C and E respectively. There was no significant 
difference (p<0.05) in total cholesterol, but we observed a significant increase in triglyceride level in BCA patients 
compared to control. Protein concentration decreased significantly (p<0.05) in BCA patients, compared to control. 
SOD and vitamin C levels were not significantly different while vitamin E decreased significantly (p<0.05) in BCA 
patients compared to control. Lipid peroxidation increased (p<0.05) in BCA patients compared to control. We 
observed an increase in AST, a decrease in ALT and total proteins in BCA patients that were significant and a 
non-significant decrease in the bilirubin level when compared with control. 
The results support the fact that BCA patients on chemotherapy have altered dietary intake and the enhanced 
metabolism of lipids and proteins may increased oxidative stress. 
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Introduction 
Breast cancer (BCA) is the most common cancer 
type in women worldwide, a major cause of 
morbidity in women, with1.15million new cases 
and 410,000 deaths in 2002 [1]. In Nigeria, the 
prevalence of BCA is about 116 per 100,000 and 
about 27,840 new cases were expected to develop 
in 1999 [2]. The relative frequency of BCA among 
other female cancer types as recorded in cancer 
registries in Nigeria are 35.4% in Ibadan, 44.5% in 
Enugu, 37.5% in Lagos, 29.8% in Calabar and 
20.5% in Zaria. This is relatively higher in 
Southwest (Ibadan) and Southeast (Enugu) regions 
compared to Northern (Zaria) and south-south 
(Calabar) regions of Nigeria. Many 
epidermiological risk factors have been identified 
and associated with BCA, and often the cause of 
individual BCA is unknown. However, BCA is 
considered to be the final outcome of multiple 
environmental, hormonal and genetic hereditary 
factors [3, 4]. Many epidemiological studies have 
suggested that dietary factors affect the risk of 
BCA, as the diet does not only provide nutrients 
but conveys other substances that may participate 
in promoting or inhibiting carcinogenesis. 
The presence of cancer may alter dietary intakes 
and the metabolism of specific nutrients [5] as well 
as patients’ treatment regime such as radiotherapy 
and chemotherapy which may have adverse effects 
on the biochemical and nutritional status of the 
patients. The relationship between lipids and breast 
cancer is not clear as conflicting results have been 
reported on the association between lipids and the 
risk of BCA [6]. Although there is a long 
established correlation between the incidence of 
BCA and dietary fats in populations [7] in lipids, 
the true relationship between fat intake and BCA, 
does not seem to be particularly consistent [8]. 
Various studies have linked dietary fat to tumor 
growth via an eicosanoids synthesis [9], 
consequently this may become an impediment on 
the effect of chemotherapy on treatment of the 
disease and the risk of BCA.  
BCA under chemotherapy may exert its effect 
via generation of reactive oxygen species (ROS) 
which induces oxidative damage to DNA and 
proteins on the one hand, while on the other hand 
increase in ROS could lead to increased lipid 
peroxidation and neoplastic transformation [10, 1]. 
Formation of lipid peroxide is normally prevented 
or scavenged by antioxidants both enzymatic and 
non-enzymatic. Experimental evidence reveals that 
reactive oxygen species are involved in initiation, 
promotion and progression of carcinogenesis where 
reactive inactivation or loss of certain tumor 
suppressor genes is concerned. The extent of ROS 
induced oxidative damage can be exacerbated by a 
decreased efficiency of antioxidant defense 
mechanism. Critical to the effects of lipid 
peroxidation products are the enzymatic and 
non-enzymatic antioxidant defense that protects the 
cells from oxidative stress through reduction of the 
reactive intermediate molecules formed. Dietary 
antioxidants consumption may be associated with 
reduced BCA risk. Humans require external 
sources of vitamins E and C through the 
consumption of antioxidant rich vegetables and 
fruits, as the body is unable to produce nutrients. In 
general the association between dietary factors and 
BCA remain controversial in the epidemiology 
literature, but there is some support for the lipid 
peroxidation pathway and protective effect from in 
vitro studies [12]. According to the findings, 
attention to plasma antioxidant vitamins and lipid 
peroxidation is of great importance to promote the 
level of health in women suffering from breast 
cancer [13]. 
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Radiation therapy and chemotherapy with their 
visible side effects can also impact on the 
nutritional and biochemical status of BCA patients. 
Apart from physical impact of these treatment 
regimens, they also can interfere with digestion and 
metabolism of nutrients. In Nigeria, the incidence 
in BCA has been on the increase and the prevailing 
economic situation has greatly affected food intake, 
hence the comparism of age, body weight matched 
healthy control to BCA patients. To our knowledge, 
such study has been carried out on the biochemical 
and nutritional status of BCA patients in Nigeria 
with respect to these parameters. This gap 
informed our decision to investigate comparatively 
the impact of the ameliorative effects supplements 
given to BCA patients on radiotherapy or 
chemotherapy with normal controls. Also to 
investigate probable differences in their lipid 
profile, enzymatic and non-enzymatic antioxidant 
status, lipid peroxidation as index of oxidative 
stress and their liver function test as marker of 
hepatotoxicity. It is hoped that the study will 
improve our understanding of nutritional and 
biochemical status of BCA patients and probable 
relationship between nutrition, chemotherapy and 
pathogenesis of BCA. 
Materials and Methods 
Cholesterol, bilurubin, Alanine aminotransferase 
(ALT), Aspartate aminotransferase (AST), and 
Triglyceride (TG) assay kits (Thermos Fischer) were 
bought from ABJ Chemicals Lagos, Nigeria. 
Adrenaline, Thiobarbituric acid (TBA), L-Ascorbic 
acid and bovine serum albumin (BSA) were 
purchased from Sigma Chemical (St Louis, MO, 
USA). All other chemicals were of the highest purity 
commercially available. 
Study Location 
Thirty BCA patients on either radiotherapy or 
chemotherapy were recruited from the 
Radiotherapy Department, University College 
Hospital (UCH) after obtaining their informed 
consent from both patients and controls. 
Furthermore, our protocol was approved by the 
College of Medicine ethical review committee of 
University of Ibadan. Patients in the middle income 
range and age- and -body weight matched healthy 
female volunteers in Ibadan North LGA. Exclusion 
criteria were presence of breast cancer, any other 
disease, mental instability and pregnancy. Thirty 
patients each and thirty controls, aged between 35 
to 60 yrs were enrolled in study. Patient samples 
were collected in UCH and that of controls from 
Biochemistry Department, University of Ibadan. 
Laboratory analyses were carried out in the 
Clinical Biochemistry laboratory in Chemical 
Pathology Department, University college Hospital, 
Ibadan and in the nutritional Biochemistry 
laboratory, University of Ibadan. 
Sample Collection 
Eight mililitres of blood was obtained by 
vein-puncture from each subject and divided 
equally into ethylenediaminetetraacetic acid EDTA 
and lithium heparin anticoagulated bottles. Blood 
in lithium heparinised bottles was centrifuged at 
300 rpm for 10 mins and the plasma was separated 
into clean tubes and stored at in the fridge until it 
was needed 
Biochemical assays 
Cholesterol was determined by cholesterol oxidase 
/peroxidase method using Randox kit by 
absorbance measurement at 490 nm when 
cholesterol reacts with FeS04 in glacial acetic acid 
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is treated with H2SO4. Triglycerides was estimated 
after enzymatic hydrolysis with lipases by 
measuring quinoneimine formed from hydrogen 
peroxide, 4-aminophenazone and 4-chlorophenol 
under catalytic influence of peroxidase as 
described by Rafai et al., 1999 [14]. HDL and 
LDL-cholesterol was determined using Human 
cholesterol liquiolor test kit [15]. The lipoproteins 
were assayed using an enzymatic colorimetric 
method for VLDL and LDL by precipitation using 
phosphotungistic acid and magnesium chloride. 
After centrifugation at 3000 g for 10min at 250C, 
the clear supernatant contained HDL fraction using 
HDL-cholesterol precipitant kit. The 
LDL-cholesterol (LDL-c) was calculated using the 
formulae of Friedwald et al. 1972 [16].  
 Lipid peroxidation was assayed using the 
method of Varshney and Kale 1990 [17] by 
estimating thiobarbituric acid reactive substances 
(TBARS) formation. SOD was determined using 
the method of Misra and Fridovich 1972 [18]. A 
simple colorimetric method, as described by Kway 
1978 [19], was used for vitamin C, and vitamin E 
was determined using a slight modification of the 
method. Serum alanine aminotransferase (ALT) 
and aspartate aminotransferase (AST) were 
determined using assay kits as described by 
Reitman and Frankel and Schmidt and Schmidt [20, 
21] respectively. Bilirubin was determined using 
assay kit by diazotizing plasma bilirubin to purple 
azobilirubin using sulphanilic acid (Ehrlich’s 
reagent). Total bilirubin was determined in the 
presence of caffeine which releases albumin bound 
to bilirubin by the reaction of diazotized 
sulphanilic acid and the absorbance measurement 
was taken at 578 nm. Plasma protein was estimated 
by Biuret method using BSA as standard [22]. 
Statistical analysis 
The results are expressed as means and standard 
deviation for the BCA patients and the controls. 
Statistical differences between group were assessed 
by the students t-test, P values less than (p<0.050) 
were considered significant. 
Results 
The anthropometric measurement data is shown on 
Table 1 and we only had a slight increase in the 
body weight of the control group compared with 
BCA patient. Table 2 shows the lipid profile of the 
BCA patients compared with the control group. The 
analysis for the lipid profile (total cholesterol, 
triglycerides, HDL Cholesterol and LDL 
cholesterol) showed that there was no significant 
difference (p<0.05) in the total cholesterol, HDL 
cholesterol and LDL cholesterol levels, but there 
was a significant increase (p<0.05) in the 
triglyceride level of BCA patient compared to 
control group. 
 
Table 1 Anthropometric measurements of apparently healthy female adult (control group) and breast 
cancer (BCA) patient. 
 
 
 
 
 
 
Values are expressed as means ± S.D. *Values are statistically significant (p<0.05) between BCA patients 
and control subjects. 
Parameters BCA              Control 
Age 42.37 ± 25.68 45.29 ± 20.77 
    weight (kg) 59.34 ±  23.78 74.51 ± 30.48* 
height (cm) 168.31 ±  13.98 169.29 ± 11.22 
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Table 2: Lipid profile, Antioxidant status (SOD, Vitamin C and E) in apparently healthy female 
 
 
 
 
 
 
 
 
 
 
 
 
Values are expressed as means ± S.D. *Values are statistically significant (p<0.05) between BCA patients 
and control subjects. 
 
The antioxidant level, which is a marker of 
oxidative stress, as well as the total plasma 
protein of the BCA patient compared with the 
normal control group, is shown on Table 3. 
There was no significant difference (p<0.05) in 
the SOD and vitamin C level but there was a 
significant decrease (p<0.05) in the vitamin E 
level of the BCA patients compared with 
control. The oxidative stress index (MDA level) 
revealed a significant increase (p<0.05) in the 
lipid peroxidation level in BCA patient 
compared to control subjects. Total protein 
analysis showed a significant decrease (p<0.05) 
in protein in BCA patients compared with 
control with mean values of 62.13±6.28 and 
76.28±7.56, respectively, thereby showing an 
18.6% decrease. 
 
Table 3 Plasma activity of Alanine amino transferase (ALT), Aspartate amino transferase (AST) and total 
bilirubin concentration in apparently healthy female adults (control) and Breast cancer (BCA) patients 
 
Parameters Control BCA Patients 
ALT (U/L) 8.60± 2.49 6.90 ± 2.87* 
AST (U/L) 16.70 ± 3.52 19.83 ± 6.03* 
Total Bilirubin (mg/dl) 0.52±0.16 0.49±0.17 
Values are expressed as means ± S.D. *Values are statistically significant (p<0.05) between BCA patients 
and control subjects. 
Table 4, shows the liver function test of the 
BCA patient compared with the control. There 
was a significant decrease (p<0.05) in ALT 
activity, a significant increase (p<0.05) in AST 
activity but there was no significant difference 
in the total bilirubin concentration of the 
breast cancer patients compared with control. 
However, the bilirubin level in the breast 
Parameters Control BCA Patients 
Total cholesterol (mg/dL) 129.57 ± 35.68 128.83 ± 40.77 
Triglyceride (mg/dL) 74.97 ±  40.78 108.83 ± 30.48* 
HDL cholesterol (mg/dL 50.77 ±  23.98 46.17 ± 28.22 
LDL cholesterol (mg/dL) 62.74 ± 26.30 61.58 ± 36.21 
SOD (mmol/mg protein) 2.04 ± 1.01 1.71 ± 1.01 
Vitamin C (mg /dL) 0.24 ± 0.12 0.24 ± 0.14 
Vitamin E (mg /dL) 9.61 ± 1.46 8.01 ± 1.60* 
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cancer patients was also lower compared to 
control group 0.493±0.17 and 0.523±0.17, 
respectively. 
 
Table 4 Lipid peroxidation and total protein levels in apparently healthy female adults and Breast cancer 
(BCA) patients. 
 
Parameters Control BCA patients 
Lipid peroxidation (mmol/mg protein) 4.98±2.85 7.80±3.18* 
Total protein (mg/g 76.28±7.56 62.13±6.28* 
Values are expressed as mean ± S.D, *Values are statistically significant (p<0.05) between BCA patients 
and control subjects 
 
 
Discussion 
Most often cancer treatment involves 
combination of radiotherapy and/ or 
chemotherapy after surgery and these could 
further potentiate oxidative stress. ROS could 
lead to gene mutation, lipid peroxidation and 
possibly neoplastic transformation. Moreover, 
the presence of BCA may alter dietary intake 
and the metabolism of specific nutrients [10], 
on its own and during management with 
chemotherapy. There was no significant 
difference in total cholesterol, high density 
lipoprotein (HDL) and low density lipoprotein 
(LDL) in this study and it might be due to 
dietary fat intake. However, the elevated level 
of plasma triglyceride in the breast cancer 
patients, when compared with control group is 
in line with the result obtained by Martyn et al. 
[23] and Shah [8] who reported significant 
higher triglyceride levels in BCA patient. This 
increase in the triglyceride level may be due to 
inhibition of adipose tissue lipoprotein lipases 
activity [23, 24]. However, in the present study 
we saw no evidence of increased triglyceride 
intake in the BCA patient compared with the 
control group. Increases in cholesterol in the 
body cells have been reported to activate cells 
and cause the production of oxygen free 
radicals, followed by oxidative stress and 
hypercholesterolemia [25].  
Analysis of antioxidant level revealed that 
there was no significant difference in SOD and 
vitamin C levels, although there was a 16.2% 
and 2.8% decrease in their levels, respectively, 
in BCA compared to control. The decrease in 
SOD activity in BCA may be due in part to 
increased utilization of SOD [26] in the 
detoxification of endogenous and exogenous 
ROS generated by chemotherapy. Antioxidant 
vitamins have a number of biological activities 
such as immune stimulation and an alteration 
of metabolic activations of carcinogens. 
Vitamin C can readily scavenge ROS, thereby 
effectively protecting cellular biomolecules 
from oxidative damage. Since free radicals can 
lead to the development of cancer, there is 
reason to believe that antioxidants help reduce 
the risk of cancer incidence, and may help the 
body’s immune system fight against BCA 
recurrence. In this study, there was no 
significant difference observed in plasma 
vitamin C concentration between the two 
groups (BCA patients and Control) which are 
in consonance with the findings of Avhgami 
[27]. Although earlier studies have observed 
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an increase in plasma vitamin C [28-30], 
which is different from our result. This finding 
may be due to the higher intake of vitamin C 
supplement by the BCA patient, especially as 
we used in -hospital patients on immune 
booster supplementation. The plasma vitamin 
E level was observed to be significantly lower 
in BCA patients compared with the control 
group in this study. Earlier studies [29-31], 
have reported decrease vitamin E 
concentration in BCA patient. The decrease in 
the plasma vitamin E may be due in part to 
increased turnover to prevent oxidative 
damage in these patients suggesting an 
increased defense against oxidant damage in 
BCA. This result indicates that in BCA cancer 
patients, the efficiency of Vitamin E in 
counteracting the damaging effects of free 
radicals may be significantly reduced. Tumor 
cells have been reported to sequester essential 
antioxidants to meet the demands of growing 
tumor [32]. The decrease in vitamin E in the 
BCA patient may be due to the continuous 
utilization of vitamin E, increased scavenging 
of lipid peroxides in response to increased 
lipid peroxidation observed in BCA patients 
and probably due to sequestration by tumor 
cells. 
Plasma activities of AST and ALT are the 
most commonly used markers of 
hepatocellular injury [33, 34], this is because 
they are intracellular enzymes which are 
released into circulation after cellular damage. 
ALT is highly specific for the liver, whereas 
AST is also located in the heart, brain, kidney 
and skeletal muscles, making the enzyme less 
specific for liver injury. Their plasma activity 
increases as a result of cellular membrane 
damage and leakage [35]. The decrease in ALT 
activity in BCA patients may indicate recovery. 
The decrease in ALT activity may also confirm 
that there is no liver damage due to 
chemotherapeutic related toxicities, and 
metastasis of cancerous cells to the liver in the 
BCA patients. The elevated AST activity in the 
BCA patient may be due to inflammation or 
damage to other organs or metastasis of the 
cancer to other organs in the body. Bilirubin 
concentration in the BCA patient was lower 
but not significantly different (p<0.05) 
compared with the control. Total bilirubin 
concentration indicates the functional transport 
capacity of the liver [36] and it exhibits potent 
antioxidant properties. This may be due in part 
to reduced hepatocytes damage and no 
increase in the breakdown of hemoglobin in 
the BCA patient. Unconjugated bilirubin 
mediated reduction of BCA cell line 
proliferation in a dose dependent manner via 
the induction of apolipoprotein D, this may 
also explain the slight reduction of bilirubin 
seen in BCA patient in conjunction with high 
triglycerides levels in an attempt to reduce 
BCA cell growth.  
The increasing global incidence of BCA 
emphasizes the need to understand its etiology, 
response to treatment, nutritive and 
biochemical well being of patients. Diet plays 
a critical role since it is not only a source of 
nutrients but also a vehicle for other 
substances that may participate in promoting 
or inhibiting the disease prognosis. We have 
shown from this study that BCA can lead to 
alteration in the metabolism of lipids and 
protein depletion, also a cumulative functional 
insufficiency of the non-enzymatic antioxidant 
system (i.e. Vitamin C and E) may play an 
essential role in the development of increased 
oxidative stress in BCA patient. The patients 
were on supplementation and this should be 
encouraged alongside ingestion of fruits and 
vegetables rich in antioxidants which is 
necessary for BCA patients to prevent 
oxidative damage, deterioration of tissues and 
treatment related toxicities. Oxidative stress 
resulting from an imbalance between ROS and 
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scavenging capacity of antioxidants induces 
damage which may progress to disease state 
and development of cancers including breast 
cancer [27]. In this study, we observed a 
marked increase in lipid peroxidation levels in 
the BCA patients. This may be attributed to 
ROS generation from treatment related 
toxicities, a deficiency of antioxidant defense 
and endogenous ROS in the BCA. Studies have 
shown lipid peroxidation increases in plasma 
in the case of solid tumor [29, 30]. The results 
of the present study are consistent with these 
findings [37-39] and in addition, Gonec et al., 
(2001) [38] also reported that a significant 
difference between plasma levels of 
Malonyldiaaldehyde (MDA) in BCA patients 
compared to control subjects. Total protein 
level in the BCA patient was significantly 
lower when compared with control. The 
marked decrease in protein concentration may 
be due to altered dietary intake, increased 
protein metabolism and increased demand of 
proteins by BCA cells. Treatment related 
toxicities in BCA patients due to nausea and 
lack of appetite may have contributed.  
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